Cronyism Blocks Another Affordable COVID Med


(From The Alliance for Natural Health)

The Frontline COVID-19 Critical Care Alliance (FLCCC) published a paper reviewing the evidence for ivermectin, an off-patent drug for river blindness, arguing that it has antiviral and anti-inflammatory properties that make it effective in the prevention and treatment of COVID. The evidence on ivermectin is, unsurprisingly, being ignored by the medical establishment because it is a cheap drug and can’t make boatloads of money for drug companies—much like hydroxychloroquine.

Click here for the article.

This article was originally posted here:

0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments

More from Against Crony Capitalism: